Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - COST OF REVENUE
Cost of Revenue PRPH - ProPhase Labs, Inc.
28.1 M
LAST VALUE
-21.97%
2 YEAR CAGR
27.52%
5 YEAR CAGR
12.91%
10 YEAR CAGR